TFX | tickerfilter.com

Fundamental analysis

52%

Profitability 47%

Dept financing 45%

Liquidity 27%

Performance 66%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

1.14%

1 Month

10.25%

3 Months

18.82%

6 Months

9.57%

1 Year

12.80%

2 Year

11.29%

Key data

Stock price

$245.17

P/E Ratio

43.83

DAY RANGE

$241.90 - $245.60

EPS

$5.57

52 WEEK RANGE

$176.52 - $256.66

52 WEEK CHANGE

$0.16

MARKET CAP

11.552 B

YIELD

0.55%

SHARES OUTSTANDING

47.117 M

DIVIDEND

$0.34

EX-DIVIDEND DATE

08/15/2024

NEXT EARNINGS DATE

10/31/2024

BETA

0.83

PUBLIC FLOAT

AVERAGE 10 VOLUME

$262,158

AVERAGE 30 VOLUME

$446,777

Company detail

CEO: Liam Kelly
Region: US
Website: https://www.teleflex.com/
Employees: 6,513
IPO year: -

Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. headquartered in wayne, pa, teleflex employs approximately 12,000 people worldwide and serves healthcare providers in more than 150 countries.

TFX - Teleflex Incorporated